Apotex Corp. Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle recall: Failed Dissolution Specifications; product failed to meet 24-month stability
Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
The hazard: Potency, impurity or stability failure
This is a specification failure: testing showed the product does not match what the label promises.
What the notice says: Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
Why it matters: The product failed a specification test: it may contain more or less active ingredient than the label states, carry an impurity, or degrade before its expiry date. A sub-potent dose can leave a condition untreated; a super-potent one can cause an overdose.
Symptoms and when to call a doctor
The risk depends entirely on the drug. For a medicine where dose matters closely — a blood thinner, an anti-epileptic, a thyroid or heart medicine, insulin — talk to your prescriber before changing anything. Seek urgent care if you have symptoms that suggest too much drug, or if the condition the medicine controls starts breaking through.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0804-2026
- Published
- September 2, 2026
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Apotex Corp.
- Product type
- Prescription & OTC drugs
- Units affected
- 6,972 bottles
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Lot # TY9494, Exp Date: 05/31/2027.
Products covered by this recall
Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-4379-3
Check your product
The notice names 9 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- TY9494
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- 05
- 31
- 2027. — 6
- 972 bottles
NDC number
On the carton and again on the bottle or blister label.
- 60505-4379-3
Package size
Match the net weight or the piece count on the front of the pack.
- 37.5 mg
- 30 count
- 9 L
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Potency
Apotex Corp. — This is a specification failure: testing showed the product does not match what the label promises.
- Check the lot number on your pack against the codes listed above before you do anything else.
- Report any change in how the medicine is working to FDA MedWatch, which is where most of these signals originate.
- Do not stop a prescription on your own. For most conditions an uncertain dose is safer than no dose while you get advice.
- Call your prescriber or pharmacist and ask whether to swap the lot, re-test, or change nothing.
Refunds and replacements
With medicines, a replacement supply matters more than cash, and that is what pharmacies are set up to provide.
- Ask the dispensing pharmacy for a like-for-like replacement from an unaffected lot. This is the fastest route and usually costs nothing.
- For a mail-order or online pharmacy, use the recall line listed on this page rather than the general support queue.
- If the recall voided a fill you had already paid for, your insurer will normally authorise a replacement ahead of schedule. Quote the recall number.
- If you paid out of pocket, ask for a refund of the co-pay or purchase price and keep the receipt the pharmacy issues.
Company contact: Apotex Corp. — 2400 N Commerce Pkwy Ste 400, Weston, FL, 33326-3253
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Apotex Corp. prescription & otc drugs recalled?
Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code TY9494; best-by date 05 or 31. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Check the lot number on your pack against the codes listed above before you do anything else.
Can I get my money back?
Ask the dispensing pharmacy for a like-for-like replacement from an unaffected lot. This is the fastest route and usually costs nothing.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 18 days ago
Apotex Corp. Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle recall: Failed dissolution specifications
Failed dissolution specifications.
-
Class II · 6 months ago
Apotex Corp. Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle recall: Defective container: defect in a batch of bottle caps
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
-
Class II · 7 months ago
Apotex Corp. Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%* recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 1+ years ago
Apotex Corp. Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5% recall: Lack of Assurance of Sterility; atypical weight loss due to improper bottle
Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
-
Class II · 1+ years ago
Apotex Corp. Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL recall: Lack of Assurance of Sterility; atypical weight loss due to improper bottle
Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
-
Class II · 11 days ago
K.C. Pharmaceuticals, Inc. Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility